Stem cell transplant vs. standard care in myeloma relapse: a Head-to-Head trial
NCT ID NCT05675319
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a donor stem cell transplant (allogeneic) works better than standard drug therapy for people with multiple myeloma that came back after initial treatment. It included adults aged 18-70 with a compatible donor. The trial was stopped early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asklepios Hospital Hamburg St. Georg
Hamburg, Free and Hanseatic City of Hamburg, 20099, Germany
-
Charité - University of Medicine Berlin
Berlin, State of Berlin, 10117, Germany
-
Helios Hospital Berlin-Buch
Berlin, State of Berlin, 13125, Germany
-
Hospital North Nürnberg
Nuremberg, Bavaria, 90419, Germany
-
Hospital Oldenburg (AöR)
Oldenburg, Oldenburg, 26133, Germany
-
Hospital of Chemnitz gGmbH
Chemnitz, Saxony, 09116, Germany
-
Philipps University Marburg
Marburg, Hesse, 35037, Germany
-
Robert-Bosch Hospital Stuttgart
Stuttgart, Baden-Wurttemberg, 70376, Germany
-
University Hospital Augsburg
Augsburg, Bavaria, 86156, Germany
-
University Hospital Bonn
Bonn, North Rhine-Westphalia, 53127, Germany
-
University Hospital Carl Gustav Carus
Dresden, Saxony, 01307, Germany
-
University Hospital Düsseldorf
Düsseldorf, North Rhine-Westphalia, 40225, Germany
-
University Hospital Essen
Essen, North Rhine-Westphalia, 45147, Germany
-
University Hospital Frankfurt/ Main
Frankfurt am Main, Hesse, 60590, Germany
-
University Hospital Halle (Saale)
Halle, Saxony-Anhalt, 06120, Germany
-
University Hospital Heidelberg
Heidelberg, Baden-Wurttemberg, 69120, Germany
-
University Hospital Jena
Jena, Thuringia, 07743, Germany
-
University Hospital Munich ( LMU)
München, Bavaria, 80336, Germany
-
University Hospital Münster
Münster, North Rhine-Westphalia, 48149, Germany
-
University Hospital RWTH Aachen
Aachen, North Rhine-Westphalia, 52074, Germany
-
University Hospital Regensburg
Regensburg, Bavaria, 93053, Germany
-
University Hospital Tübingen
Tübingen, Baden-Wurttemberg, 72076, Germany
-
University Hospital of Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
University Hospital of Schleswig-Holstein (Campus Kiel)
Kiel, Schleswig-Holstein, 24105, Germany
-
University Hospital of Ulm
Ulm, Baden-Wurttemberg, 89081, Germany
-
University Hospital of Würzburg
Würzburg, Bavaria, 97070, Germany
-
University Hospital of the Technical University Munich rechts der Isar
München, Bavaria, 81675, Germany
-
University Medical Center Göttingen
Göttingen, Lower Saxony, 37075, Germany
-
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, 20246, Germany
-
University Medical Center Mainz
Mainz, Rhineland-Palatinate, 55131, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Can a cancer drug reboot the immune system after a stem cell transplant?
- A One-Shot gene therapy could take on incurable blood cancer
- New PET tracer could sharpen diagnosis of blood cancers
- Web tool aims to empower rare cancer patients in genomic choices
- Diabetes drug metformin could boost myeloma treatment